Nerve pain risk study for cancer patients
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study looks at why some people with cancer develop nerve pain (neuropathic pain) during treatment. By tracking your health and symptoms, researchers hope to find ways to predict and prevent this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have breast, gynecologic, colorectal, or lung cancer.
- You are about to start or are currently having cancer treatment such as chemotherapy, surgery, radiation, or hormone therapy.
- You are able to understand and follow the study instructions and can give oral consent.
- You are covered by the French Social Security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict and improve pain you may have months after radiotherapy for first head and neck cancer. It may help doctors better anticipate pain and support patients during recovery.
This trial tests whether a small implanted device that sends mild electrical signals to your spinal cord can reduce pain caused by chemotherapy drugs. If you have long-lasting nerve pain in your legs from cancer treatment that hasn't improved with medications, this study may help.
This trial tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation, can reduce chronic nerve pain caused by cancer or its treatment. It may help patients who have not found relief from standard pain medications.
This study tests a special laser treatment (photobiomodulation) to reduce nerve pain caused by chemotherapy in cancer patients. If you have had nerve pain for at least 3 months after chemo and can attend twice-weekly sessions, this may help ease your pain.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This study looks at nerve-related symptoms and pain in the mouth and throat in people who have been treated for oral or oropharynx cancer. You may be able to take part if you’re within 1 to 5 years after treatment and can follow study steps.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.